Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • COR vs GSK✓SelectedUSD · GSKCOR vs GSK performance historyLatest closeAs of-0.63%11/20
Stock and ETF performance explorer

COR vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+477.1%
GSK return
+97.4%
Excess return
+379.7%
Maximum drawdown
-32.4%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-0.6%-0.1%-0.5%-0.6%
7D-5.6%-5.3%-0.2%-3.6%
30D-0.2%-3.7%+3.5%+1.2%
3M+8.0%-7.3%+15.2%+10.9%
6M+28.6%-4.2%+32.8%+30.2%
YTD+1.2%+0.9%+0.3%-0.4%
1Y-5.6%+7.3%-12.9%-9.5%
3Y+77.3%+52.7%+24.6%+40.5%
5Y+198.5%+40.1%+158.3%+140.5%
All+477.1%+97.4%+379.7%+253.1%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling